Core Viewpoint - The company has approved the conclusion of two fundraising investment projects and plans to permanently supplement its working capital with the remaining funds from these projects [1] Group 1: Project Conclusion - The company held its 24th meeting of the second board on December 26, 2025, where it approved the conclusion of the "New Generation Electric Drive System Industrialization Project" and the "Information System Construction and Upgrade Project" [1] - Both projects have reached the predetermined usable status as of the announcement date [1] Group 2: Remaining Funds - The total remaining funds from the two projects amount to 70.43 million yuan, with 46.88 million yuan from the electric drive system project and 23.54 million yuan from the information system project [1] - The surplus is primarily due to net bank deposit interest received after deducting bank fees and cash management income [1] Group 3: Fund Utilization - The remaining funds are intended to be permanently used to supplement working capital, with the actual amount based on the balance of the special account on the day of the fund transfer [1] - The matter is subject to approval by the company's shareholders' meeting [1] - After the transfer of all fundraising funds, the company will cancel the corresponding fundraising special account [1]

Group 1 - Jiangsu province has a unique geographical advantage in shipbuilding and offshore engineering, maintaining the top position in the industry for over a decade, with significant shipbuilding bases in Nantong, Yangzhou, and Jingjiang [1] - From January to July, the high-tech shipbuilding and offshore equipment cluster in Jiangsu achieved a value-added growth of 14.6% year-on-year, indicating a strong growth trend [1] - In 2024, Jiangsu's shipbuilding completion volume, new orders, and hand-held orders are projected to account for 47.36%, 46.22%, and 46.94% of the national totals, respectively [1] Group 2 - The shipbuilding industry faces challenges such as a shortage of skilled workers and the need for efficiency improvements, with the average age of technical workers being higher than in other industries [1] - Jiangsu has launched a three-year action plan (2025-2027) to deepen the intelligent transformation, digitalization, and networking of the manufacturing industry [2] Group 3 - Many shipbuilding companies have begun implementing intelligent management systems, such as steel material management software, which has halved the steel inventory from approximately 7.5 million to 8 million tons, significantly improving capital efficiency [3] - The implementation of information systems has reduced the average inventory cycle from 15 days to about 6 days, increasing manufacturing efficiency by 30% and reducing labor intensity [3] Group 4 - The provincial government aims to significantly reduce labor intensity in processes like cutting, forming, welding, and painting, while enhancing management precision and information integration in shipbuilding enterprises [4] - The intelligent processing workshops in Jiangsu showcase advancements such as automated operations and efficient material handling, leading to substantial increases in production efficiency [5]

Core Viewpoint - Jiangsu province has established itself as a leading hub for shipbuilding and marine engineering in China, with significant growth in high-tech shipbuilding and marine equipment sectors, achieving a value-added growth of 14.6% year-on-year from January to July 2023 [1][2]. Group 1: Industry Overview - Jiangsu's shipbuilding and marine engineering industry has maintained its position as the top in the country for over a decade, with major shipbuilding bases in Nantong, Yangzhou, and Jingjiang [1]. - In 2024, Jiangsu's shipbuilding completion volume, new orders, and hand-held orders are projected to account for 47.36%, 46.22%, and 46.94% of the national totals, respectively [1]. Group 2: Challenges Faced - The shipbuilding industry is experiencing a shortage of skilled workers, with an average age of workers being higher than in other sectors, leading to efficiency challenges [2]. - The complexity and large volume of work in shipbuilding require extensive coordination among various trades and departments, consuming significant time and resources [2]. Group 3: Solutions and Innovations - Jiangsu has launched a three-year action plan (2025-2027) to enhance the intelligent, digital, and networked transformation of the manufacturing sector [3]. - Companies are implementing smart management systems, such as steel material management software, which has halved inventory levels and significantly improved efficiency [4]. - The introduction of information systems has reduced inventory cycles from 15 days to approximately 6 days, increasing manufacturing efficiency by 30% and reducing labor intensity [4][6]. Group 4: Future Prospects - The provincial government aims to significantly reduce labor intensity in key shipbuilding processes and enhance management precision and information integration within three years [5]. - The ongoing "smart transformation" initiatives are expected to further boost production capacity and economic benefits, solidifying Jiangsu's status as the leading shipbuilding province in China [6].

Group 1 - Two companies announced private placement plans on August 1 [1] - Siquan New Materials plans to raise 466 million yuan, primarily for projects in Vietnam and working capital [1] - Longhua Chemical aims to raise 230 million yuan for its carbon dioxide polyether project [1] Group 2 - Siquan New Materials' stock price increased by 45.04% over the past five days, while Longhua Chemical's stock price decreased by 4.15% [1] - The latest closing prices are 103.66 yuan for Siquan New Materials and 21.73 yuan for Longhua Chemical [1]

Market Growth and Challenges - The domestic medical device market has experienced a compound annual growth rate (CAGR) of 20% due to new infrastructure initiatives and government support, but is currently facing challenges due to tight local fiscal conditions [2][3] - The issuance of medical special bonds has seen a rapid year-on-year growth, indicating a potential recovery in hospital equipment procurement [3] - Monthly bidding data for various medical devices has been continuously recovering since December 2024, although the time from bidding to revenue recognition has significantly lengthened [3][6] Long-term Market Potential - The company believes that the long-term growth potential in the domestic market remains substantial, driven by an aging population and increasing demand for quality medical resources [3][4] - The company is expanding its market reach through internal R&D and external acquisitions, focusing on "equipment + IT + AI" digital solutions [3][4] Competitive Advantages - The company has transitioned through three growth phases: price advantage, engineering advantage, and now technology innovation, which positions it uniquely against international competitors [4][6] - As the only company headquartered in a developing country among the top 50 medical device firms globally, the company has established a broad and deep business layout that surpasses international brands [4][6] Financial Performance - In Q1 2025, domestic revenue declined over 20% year-on-year but increased by over 50% compared to Q4 2024, reflecting a recovery trend [6][7] - International business growth was less than 5% year-on-year, but the compound growth rate over the past two years exceeds 15%, with developing countries showing nearly 19% growth [6][7] Future Outlook - The company anticipates a significant turning point in domestic business starting Q3 2025, supported by the resumption of medical equipment update projects [7] - The international market is expected to see a recovery in growth rates, particularly in developing countries, due to ongoing localization efforts [7] Revenue Contributions by Business Line - In 2024, the in-vitro diagnostics (IVD) segment generated revenue of 13.765 billion, growing 10.82% year-on-year, with international IVD growth at 30% [11][12] - The medical imaging segment achieved revenue of 7.498 billion, with international growth exceeding 15% [11] - The life information and support segment generated 13.557 billion, with minimally invasive surgery growing over 30% [11] Strategic Investments - The company has invested in Huatai Medical, acquiring a 20% stake to enhance its presence in the cardiovascular sector and foster new growth points [9][10] - The collaboration aims to leverage resource integration for product innovation and operational efficiency, particularly in the three-dimensional electrophysiology systems [10]

证券代码：603195 证券简称：公牛集团 公告编号：2025-003 公牛集团股份有限公司 关于部分募集资金投资项目延期的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 拟实施延期项目的名称及其情况：基于募集资金投资项目实际建设情况， 经公牛集团股份有限公司（以下简称"公司"）审慎研究，拟对募集资金投资项 目"信息化建设项目"的预定可使用状态日期延长至 2026 年 2 月。 公司于2025年2月27日召开了第三届董事会第八次会议及第三届监事会第七 次会议，审议通过了《关于部分募集资金投资项目延期的议案》。公司根据目 前募集资金投资项目（以下简称"募投项目"）的实施进度，在募投项目实施 主体、投资用途和投资规模不变的情况下，决定对"信息化建设项目"的预定 可使用状态日期进行延期。现将有关事项公告如下： 一、募集资金的基本情况 根据中国证券监督管理委员会出具的《关于核准公牛集团股份有限公司首 次公开发行股票的批复》（证监许可〔2019〕3001号），公司首次公开发行6,000 万股人民币普通股（A股）股票 ...